Hospital parking charges rise 'necessary'
The increase will be between 30p and 60p for up to four hours, although the first 20 minutes, for pick-up and drop-offs, will remain free.
The move affects Middlesbrough's James Cook University Hospital, the University Hospital of North Tees in Stockton, the University Hospital of Hartlepool, Peterlee Community Hospital and Northallerton's Friarage.
Steve Taylor, of University Hospitals Tees (UHT), has previously said it was understood the move would not be welcome, but the cost of maintaining the car parks could not be covered by its current operating budget.
Anything left over from running costs would be diverted to patient care, he pledged.
Parking will still be free for the first 20 minutes, for blue badge holders, frequent outpatient attendees, and the parents of sick children admitted to hospital overnight.
Mr Taylor told the Local Democracy Reporting Service: "Charging for parking ensures only those who need to visit our hospitals use a parking space and ensures a swift turnover of spaces.
"We would like to reassure all our patients and visitors that the income is used to maintain our car parks, including the costs of repairs and maintenance, lighting, gritting and security.
"Any surplus money is diverted into patient care to support the delivery of front-line services."
Follow BBC Tees on X, Facebook, Nextdoor and Instagram.
Hospital parking charges to increase
Hospital staff protest over planned parking change
North Tees and Hartlepool NHS Foundation Trust
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Prudential Financial to pay $100 million in US FTC settlement
(Reuters) -The U.S. Federal Trade Commission reached a $100 million settlement with Prudential Financial to resolve claims a former unit misled consumers into buying healthcare plans that did not provide the coverage it promised. A settlement with Assurance IQ, which Prudential decided to shut down last year, was filed on Wednesday in Seattle federal court. Assurance did not admit or deny wrongdoing. The FTC accused Assurance of targeting consumers in need of low-cost insurance coverage, both online and in telemarketing calls, with representations that its healthcare plans provided comprehensive coverage and essential health benefits of the sort provided under the Affordable Care Act. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
23 minutes ago
- Yahoo
CareDx Announces Appointment of Nathan Smith as Chief Financial Officer
BRISBANE, Calif., August 06, 2025--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the appointment of Nathan Smith to the role of Chief Financial Officer. Nathan will lead key financial and accounting initiatives that are a part of the Company's long-term strategic growth plan. Nathan brings more than 14 years of experience in the molecular diagnostics industry, including senior finance leadership roles at Myriad Genetics and recent CFO positions at Blackrock Neurotech and WIN Brands. "Nathan's deep financial expertise in molecular diagnostics is a great fit for CareDx," said John Hanna, CEO of CareDx. "His track record of operational excellence and experience in supporting diagnostics companies to scale efficiently will be invaluable as we enter our next phase." In conjunction with this appointment, the Company also announced that Abhishek Jain will be retiring from his role as Chief Financial Officer. Abhishek will continue to support CareDx in a consulting capacity to ensure a seamless transition. "On behalf of the Board and the entire CareDx team, I want to express my sincere gratitude to Abhishek for his outstanding leadership as CFO," said John Hanna. "Abhishek's disciplined financial management, stewardship through our CEO transition, and dedication to strengthening our finance function have positioned CareDx for continued success. We wish him all the best." About CareDx CareDx, Inc., headquartered in Brisbane, California, is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. For more information, visit Forward Looking Statements This press release includes forward-looking statements related to CareDx, Inc. These forward-looking statements are based upon information that is currently available to CareDx and its current expectations, speak only as of the date hereof, and are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including general economic and market factors and other risks discussed in CareDx's filings with the SEC, including, but not limited to, the Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed by CareDx with the SEC on February 28, 2025, the Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 filed by CareDx with the SEC on April 30, 2025, and other reports that CareDx has filed with the SEC. Any of these may cause CareDx's actual results, performance, or achievements to differ materially and adversely from those anticipated or implied by CareDx's forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements. CareDx expressly disclaims any obligation, except as required by law, or undertaking to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise. View source version on Contacts CareDx Media Contacts Natasha Moshirian Wagnernwagner@ Investor RelationsCaroline Cornerinvestor@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Trump claims Japan to import F-150s amid US tariff deal uncertainty
US President Donald Trump has reportedly said that Japan is set to begin importing Ford's F-150 pickup trucks, signalling a potential misunderstanding between the two nations regarding the specifics of a trade agreement proclaimed last month, according to Bloomberg. Tokyo's chief negotiator, Ryosei Akazawa, embarked on a trip to Washington with the intention of urging the Trump administration to honour its commitment to lower tariffs on automobiles and auto parts to 15% from the current 27.5%. Akazawa told reporters, 'It's worth noting that the US-UK agreement took 54 days to be implemented,' when discussing the anticipated reduction in auto tariffs upon his arrival in Washington. Speaking of Japan in a phone interview broadcast by CNBC, Trump stated: 'They're taking our cars. They're taking the very beautiful Ford F-150, which does very well. And I'm sure we'll do very well there and other things that do very well here, will also do well there.' The trade deal between the nations has been shrouded in uncertainty, raising concerns in Japan about its execution, especially concerning autos. The Trump administration's narrative on trade agreements has frequently been at odds with that of its trade partners, leading to questions about the agreements' effectiveness. Currently, the US imposes a 27.5% tariff on Japanese autos, a figure that combines an earlier 2.5% rate with a new 25% introduced by Trump. Although a reduction to 15% would alleviate some pressure, this rate would still affect the sector that is central to the Japanese economy. Optimism in Asian markets was evident as Akazawa made his ninth visit to the US, with Japan's Topix Index climbing 1%, buoyed by gains from automakers such as Toyota Motor. A point of contention remains whether the proposed 15% tariff will be an additional charge on top of current tariffs or if all current levies will be standardised to 15%, marking another potential area of misunderstanding between the two countries' interpretations of the trade deal. Despite Akazawa's assertion that tariffs will be capped at 15% and not added to existing rates, a recent executive order suggested that the 15% reduction would only apply to the European Union, not to Japan. Trump has often expressed frustration over the lack of popularity of US cars in Japan, but many experts believe this is due to the absence of models suited to the Japanese market, rather than trade barriers. The Ford F-150 mentioned by Trump may limit its practicality on Japan's narrower roads, where many are less than four metres wide for two lanes, as per government data from 2012. In the CNBC interview, Trump likened the $550bn investment package agreed upon with Japan in the trade deal to a "signing bonus". However, the Japanese have clarified that only a small fraction of this amount will constitute actual investment, with the remainder being loans and loan guarantees. Japan's Prime Minister Shigeru Ishiba has stated that these investments, driven by private companies, will serve the interests of both countries. "Trump claims Japan to import F-150s amid US tariff deal uncertainty – report" was originally created and published by Just Auto, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
